Lu Fan

3.1k total citations
39 papers, 2.4k citations indexed

About

Lu Fan is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Lu Fan has authored 39 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Lu Fan's work include Bioactive Compounds and Antitumor Agents (4 papers), Natural product bioactivities and synthesis (4 papers) and Bioactive natural compounds (4 papers). Lu Fan is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Natural product bioactivities and synthesis (4 papers) and Bioactive natural compounds (4 papers). Lu Fan collaborates with scholars based in Singapore, Australia and China. Lu Fan's co-authors include Gautam Sethi, Frank Arfuso, Ajaikumar B. Kunnumakkara, Kishore Banik, Kwang Seok Ahn, Ganesan Padmavathi, Muthu K. Shanmugam, Sosmitha Girisa, Devivasha Bordoloi and Vivek DESHPANDE and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lu Fan

38 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Fan Singapore 23 1.2k 526 442 330 326 39 2.4k
Fanghua Qi China 21 1.2k 0.9× 380 0.7× 432 1.0× 275 0.8× 296 0.9× 39 2.2k
Sosmitha Girisa India 25 1.1k 0.9× 271 0.5× 302 0.7× 331 1.0× 269 0.8× 59 2.2k
Xueting Cai China 29 1.5k 1.2× 341 0.6× 275 0.6× 400 1.2× 226 0.7× 83 2.6k
Jingwei Zhang China 30 1.2k 0.9× 439 0.8× 358 0.8× 335 1.0× 175 0.5× 144 2.4k
Seung Hyun Oh South Korea 30 1.4k 1.1× 402 0.8× 220 0.5× 440 1.3× 243 0.7× 100 2.6k
Choudhary Harsha India 21 1.2k 1.0× 226 0.4× 262 0.6× 274 0.8× 393 1.2× 28 2.3k
Ghulam Jilany Khan China 24 1.2k 1.0× 297 0.6× 276 0.6× 295 0.9× 283 0.9× 76 2.8k
Parama Dey India 29 1.2k 1.0× 491 0.9× 165 0.4× 315 1.0× 318 1.0× 50 2.2k
Wu‐Hsien Kuo Taiwan 29 1.1k 0.9× 341 0.6× 335 0.8× 391 1.2× 430 1.3× 69 2.7k
Jung‐Il Chae South Korea 29 1.3k 1.0× 250 0.5× 345 0.8× 208 0.6× 174 0.5× 84 2.1k

Countries citing papers authored by Lu Fan

Since Specialization
Citations

This map shows the geographic impact of Lu Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Fan more than expected).

Fields of papers citing papers by Lu Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Fan. The network helps show where Lu Fan may publish in the future.

Co-authorship network of co-authors of Lu Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Fan. A scholar is included among the top collaborators of Lu Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Fan. Lu Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Panpan, Pengying Wu, Lantian Wang, et al.. (2024). Lysosome‐Targeting Bacterial Outer Membrane Vesicles for Tumor Specific Degradation of PD‐L1. Small. 20(43). e2400770–e2400770. 8 indexed citations
2.
Wang, Li, Lu Fan, Anne M. Filppula, et al.. (2024). Spatiotemporal responsive hydrogel microspheres for the treatment of gastric cancer. SHILAP Revista de lepidopterología. 5(5). 5 indexed citations
3.
Ji, Panpan, Rui Zheng, Lu Fan, et al.. (2024). Truncated PD1 Engineered Gas‐Producing Extracellular Vesicles for Ultrasound Imaging and Subsequent Degradation of PDL1 in Tumor Cells. Advanced Science. 11(12). e2305891–e2305891. 8 indexed citations
5.
Lin, Meng C., et al.. (2024). Effects of eyelid pressure on corneal tomography and biomechanics: Quantitative analysis using a novel blepharo-tensiometer. Contact Lens and Anterior Eye. 47(6). 102313–102313.
6.
Lin, Xiang, Lu Fan, Li Wang, et al.. (2023). Fabricating biomimetic materials with ice‐templating for biomedical applications. SHILAP Revista de lepidopterología. 2(3). e20230017–e20230017. 25 indexed citations
7.
Chen, Peiqiong, et al.. (2022). Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker. BMC Medical Genomics. 15(1). 29–29. 11 indexed citations
8.
He, Xu, et al.. (2022). CBXs-related prognostic gene signature correlates with immune microenvironment in gastric cancer. Aging. 14(15). 6227–6254. 9 indexed citations
9.
Banik, Kishore, Choudhary Harsha, Sosmitha Girisa, et al.. (2020). Piceatannol: A natural stilbene for the prevention and treatment of cancer. Pharmacological Research. 153. 104635–104635. 161 indexed citations
10.
Halim, Clarissa Esmeralda, Lu Fan, Frank Arfuso, et al.. (2019). Anti-cancer effects of oxymatrine are mediated through multiple molecular mechanism(s) in tumor models. Pharmacological Research. 147. 104327–104327. 66 indexed citations
11.
Ong, Samantha, Muthu K. Shanmugam, Lu Fan, et al.. (2019). Focus on Formononetin: Anticancer Potential and Molecular Targets. Cancers. 11(5). 611–611. 143 indexed citations
12.
Roy, Nand Kishor, Parama Dey, Kishore Banik, et al.. (2019). An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases. International Journal of Molecular Sciences. 20(17). 4101–4101. 169 indexed citations
13.
Jung, Young Yun, et al.. (2018). Potential Anti-Inflammatory and Anti-Cancer Properties of Farnesol. Molecules. 23(11). 2827–2827. 118 indexed citations
14.
Shabnam, Bano, Ganesan Padmavathi, Kishore Banik, et al.. (2018). Sorcin a Potential Molecular Target for Cancer Therapy. Translational Oncology. 11(6). 1379–1389. 60 indexed citations
15.
Padmavathi, Ganesan, Kishore Banik, Javadi Monisha, et al.. (2018). Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression. Cancer Letters. 432. 260–271. 90 indexed citations
16.
Banik, Kishore, Vivek DESHPANDE, Ganesan Padmavathi, et al.. (2018). Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer. International Journal of Molecular Sciences. 19(8). 2362–2362. 140 indexed citations
17.
Lee, Lawrence Soon-U, Kok‐Yong Seng, Lingzhi Wang, et al.. (2016). Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI. PLoS ONE. 11(1). e0147681–e0147681. 5 indexed citations
18.
Watanabe, Satoru, Abhay P. S. Rathore, Cynthia Sung, et al.. (2012). Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial. Antiviral Research. 96(1). 32–35. 79 indexed citations
19.
Lee, How Sung, Boon Cher Goh, Lu Fan, et al.. (2003). Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients. British Journal of Clinical Pharmacology. 55(3). 270–277. 6 indexed citations
20.
Goh, Boon-Cher, Soo Chin Lee, Lingzhi Wang, et al.. (2002). Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping Strategies. Journal of Clinical Oncology. 20(17). 3683–3690. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026